A new Weill Cornell Medicine study solves a 50-year mystery and suggests that faulty mRNA modification may underlie some autoimmune and inflammatory disorders.
Twelve Cornell and Weill Cornell Medicine faculty members – six of whom are also Cornell alumni – have been elected fellows of the American Association for the Advancement of Science, the world’s largest general scientific society.
A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.
Building off years of partnership with New York and national labor leaders to foster high-quality, climate-friendly employment that advances equity, the ILR School Climate Jobs Institute is launching Jan. 25 in New York City.
The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-institutional preclinical study led by Weill Cornell Medicine investigators.
A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine.
The National Institute on Aging of the National Institutes of Health has awarded a grant to Weill Cornell Medicine to develop a screening tool and intervention for elder neglect in patients with Alzheimer’s disease and related dementias.
A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine and the New York Genome Center.
